Eylea
Sponsors
Bayer AG, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's, Maturi, Raj K., M.D., P.C., Ophthotech Corporation, Mylan Pharmaceuticals Inc
Conditions
Age Related Macular DegenerationDiabetic Macular EdemaDiabetic Macular Edema (DME)Exudative Age Related Macular DegenerationIdiopathic Polypoidal Choroidal VasculopathyMacular edema secondary to retinal vein occlusionNeovascular Age-Related Macular DegenerationNeovascular Age-related Macular Degeneration
Phase 1
Phase 2
Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD
CompletedNCT02732899
Start: 2016-04-30End: 2017-04-04Updated: 2018-02-14
ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)
WithdrawnNCT03374670
Start: 2018-11-30End: 2019-12-31Updated: 2024-02-21
Combination OZURDEX® & EyLea® vs. OZURDEX® Monotherapy in IncompLete-Responders wIth Diabetic Macular Edema
WithdrawnNCT03629210
Start: 2019-09-30End: 2021-05-31Updated: 2019-11-13
Safety Study of Zimura in Combination With Anti-VEGF Therapy in Patients With Neovascular AMD
TerminatedNCT05571267
Start: 2016-10-20End: 2018-04-24Updated: 2025-03-13
Phase 3
Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME)
CompletedNCT03610646
Start: 2018-08-23End: 2021-09-10Updated: 2023-03-07
A Study to Compare LY09004 and Eylea in the Treatment of Wet Age-related Macular Degeneration（wAMD）
NCT04572698
Start: 2020-11-30End: 2023-12-31Target: 416Updated: 2020-10-01
Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema
CompletedNCT04739306
Start: 2021-07-22End: 2023-04-24Updated: 2023-12-05
(22153) Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion
CompletedCTIS2022-502174-16-00
Start: 2023-09-13End: 2025-05-14Target: 255Updated: 2025-06-02
Phase 4
Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD)
CompletedNCT02142296
Start: 2014-05-31End: 2016-11-30Updated: 2017-02-16
One Year Trial Evaluating Safety of Ozurdex With Eylea
CompletedNCT03984110
Start: 2019-06-11End: 2022-10-27Updated: 2024-04-10